Comparing two psoriasis drugs for adults over 70
Treatments studied
Part of Skin clinical trials.
This trial compares ixekizumab and secukinumab to see which works better for people over 70 with plaque psoriasis. It aims to find a safer and more effective treatment for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older.
- You have had plaque psoriasis for at least 6 months, with or without psoriatic arthritis.
- Your psoriasis covers at least 3% of your body, or your doctor has given you a severity score of at least 3.
- Your doctor determines that you are a good candidate for biologic or systemic treatment.
- You have not used other systemic treatments (like steroids or methotrexate) in the past 4 weeks.
- You have not taken part in another clinical trial in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well ixekizumab (an injection medication) works for moderate-to-severe plaque psoriasis, and what happens when the treatment is withdrawn. It may help you learn whether stopping the medicine is safe and how skin disease outcomes change over time.
This Phase 4 study looks at how well a psoriasis medicine called secukinumab works, and what happens when treatment is stopped in people with moderate-to-severe plaque psoriasis. It may help show the best way to manage symptoms and prevent flare-ups.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This study compares a proactive approach (adjusting drug levels based on regular blood tests) versus the usual way of using biologics for psoriasis. It helps see if active monitoring can improve treatment while keeping you safe.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests an experimental drug called ICP-488 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve symptoms and is safe, and may be an option if you need stronger treatment than creams or light therapy.
Hear when a new Over 70-year-old Patients with Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.